Redefining the value in partnerships ahead of DCAT Week

As the industry emerges from a prolonged funding slowdown, the roundtable highlights cautious optimism. Rather than a broad-based recovery, participants describe a selective, research-driven uptick focused on clinic-ready assets and higher-complexity modalities. Discussions have shifted from speculative experimentation to practical considerations, including manufacturability, timeline efficiency and the ability to scale reliably. This suggests growth that is deliberate, technology selective and weighted toward assets with clearer commercial pathways.

LATEST VIDEO

Latest news

25th March 2026

Kindeva® commemorates 70 years of the pMDI as inventors are inducted into the ‘National Inventors Hall of Fame’

25th March 2026

Merck braces for Keytruda patent loss with $6.7 billion Terns bet

24th March 2026

OLON ADVANCE GLOBAL EXPANSION AND SUSTAINABLE BIOMANUFACTURING EXPERTISE AT DCAT NEW YORK

24th March 2026

INDENA UNVEILS ENHANCED HPAPI AND TARGETED THERAPY CAPABILITIES AT DCAT WEEK 2026

19th March 2026

LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites

19th March 2026

SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment

17th March 2026

Biopharma’s Growing Emphasis on Highly Potent Drugs Drives Axplora Manufacturing Expansion

16th March 2026

Piramal Pharma Solutions’ Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch

16th March 2026

Sartorius launches next-generation platform to boost efficiency in cell therapy production

16th March 2026

Lab Thread launches free version of Unified Lab Software Platform to accelerate academic research

16th March 2026

Kindeva Appoints Mike Cowhig as Chief Legal Officer

This week’s featured articles

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Axplora: Mastering complexity

Partnered with top industry events and organisations